Abbott Laboratories (ABT)
Market Open
2 Sep, 19:26
$
110. 88
+1.94
+1.7856%
$
190.95B Market Cap
36.49 P/E Ratio
0.28% Div Yield
5.56M Volume
4.44 Eps
$ 108.93
Previous Close 
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories (ABT) Statistics
Valuation metrics
Market Cap 190.95B
Enterprise value 222.12B
Trailing P/E (ttm) 36.16
Forward P/E 15.29
PEG ratio -0.59
Price/Sales (ttm) 4.18
Price/Book (mrq) 3.84
Enterprise Value/Revenue 4.77
Enterprise Value/EBITDA 22.34
Overview
Shares outstanding 1.74B
Float 1.73B
Shares short 23.83M
% Held by insiders 0.01%
% Held by institutions 0.82%
Average volume (10 days) 8.27M
Average volume (90 days) 12.22M
Price summary
52-Week low 81.97
52-Week high 137.49
Beta 0.78
50-Day moving average 107.01
200-Day moving average 101.75
Dividends and splits
Forward annual dividend rate 2.52
Forward annual dividend yield 0.0273%
Trailing annual dividend rate 2.48
Trailing annual dividend yield 0.0221%
5-Year annual dividend yield 1.77%
Payout ratio 0.79
Dividend Date 17 Aug 2026
Ex-Dividend Date 15 Jul 2026
Last split factor 10,000:4,798
Last split Date 2 Jan 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.12%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.11%
Income Statement
Revenue (ttm) 45.13B
Revenue per share (ttm) 26.73
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 25.49B
EBITDA 12.03B
Net income to common (ttm) 6.25B
Diluted EPS (ttm) 3.11
Quarterly earnings growth (yoy) -0.19%
Balance Sheet
Total cash (mrq) 8.94B
Total cash per share (mrq) 3.21
Total debt (mrq) 14.14B
Total Debt/Equity (mrq) 0.64
Current ratio (mrq) 1.38%
Book value per share (mrq) 29.7
Cash Flow
Cash flow statement 10.8B
Levered free cash flow (LFCF) 13.77B
